Pulmonary embolism (PE) is a potentially life-threatening condition that requires prompt diagnosis and treatment. Unfortunately, due to its nonspecific signs and symptoms, diagnosis of PE can be challenging. The Wells Criteria is a simple, validated tool that can be used to help diagnose pulmonary embolism in patients with suspected deep vein thrombosis. It is important for physicians to understand the potential of the Wells Criteria and how to use it effectively to diagnose PE.
Pulmonary embolism is a blockage of an artery in the lungs caused by a clot, usually originating from a deep vein thrombosis (DVT) in the legs. It is a potentially life-threatening condition that requires prompt diagnosis and treatment. Unfortunately, due to its nonspecific signs and symptoms, diagnosis of PE can be challenging. The Wells Criteria is a simple, validated tool that can be used to help diagnose pulmonary embolism in patients with suspected deep vein thrombosis. It was first described by Wells et al. in 1995 and has since been validated in numerous studies. The Wells Criteria is a clinical prediction rule that uses a combination of clinical signs and symptoms, laboratory tests, and imaging studies to calculate a probability of pulmonary embolism.
The Wells Criteria is a clinical prediction rule that uses a combination of clinical signs and symptoms, laboratory tests, and imaging studies to calculate a probability of pulmonary embolism. The criteria is based on six factors: clinical signs and symptoms, D-dimer testing, imaging studies, prior DVT or PE, alternative diagnosis, and age. Each factor is assigned a point value, and the total score is used to determine the probability of pulmonary embolism. The Wells Criteria can be used to help diagnose pulmonary embolism in patients with suspected deep vein thrombosis. It is important to note that the Wells Criteria should not be used as a stand-alone diagnostic tool; rather, it should be used in conjunction with other clinical signs and symptoms, laboratory tests, and imaging studies to make a diagnosis.
In order to effectively utilize the Wells Criteria, physicians should first assess the patient’s likelihood of PE based on clinical signs and symptoms. This includes evaluating for signs and symptoms of DVT such as swelling, pain, and tenderness in the affected leg, as well as signs and symptoms of PE such as chest pain, shortness of breath, and tachycardia. Next, physicians should order laboratory tests, such as a D-dimer test, to assess for the presence of a clot. Imaging studies, such as a CT scan, can also be used to help diagnose PE. If the patient has a prior history of DVT or PE, this should also be taken into consideration. Finally, physicians should consider alternative diagnoses that could explain the patient’s signs and symptoms. Age is also a factor, as the risk of PE increases with age. Once all of these factors have been evaluated, the Wells Criteria can be used to calculate the probability of pulmonary embolism.
The Wells Criteria is a simple, validated tool that can be used to help diagnose pulmonary embolism in patients with suspected deep vein thrombosis. It is important for physicians to understand the potential of the Wells Criteria and how to use it effectively to diagnose PE. By assessing clinical signs and symptoms, ordering laboratory tests, performing imaging studies, and considering alternative diagnoses, physicians can use the Wells Criteria to calculate the probability of pulmonary embolism and make an informed diagnosis.
1.
Can Prior Authorization Be Better With Artificial Intelligence?
2.
One-third of childhood cancer survivors experience significant fear that it could come back, study reveals
3.
First-Line Combination for Bladder Cancer Not Eligible for Cisplatin Just Misses Positive Outcome.
4.
No increased risk of childhood cancer near UK nuclear sites, study finds
5.
A promising medication could slow brain tumors in children.
1.
Advancing Cancer Care: Insights into Oncology Trials, Immunotherapy, and CAR-T Innovations
2.
How Parvovirus B19 Affects Pregnant Women and Their Unborn Babies
3.
Beyond the Human Eye: How AI Is Redefining Brain Cancer Diagnosis Through Advanced Imaging
4.
Revolutionizing Cancer Treatment: The Promise of Bevacizumab Injections
5.
Beta-2 Microglobulin: Function, Role in Disease & Clinical Significance Explained
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
2.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
3.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation